FTC Broadens Notification Requirements for Transfers of Pharmaceutical Patent Rights
By EsqSocial Corporation 13/11/13
The Federal Trade Commission (FTC) has revised the rule for determining when a transfer of exclusive rights to a patent in the pharmaceutical industry (including biologics and medicine manufacturing) results in a potentially reportable asset...
By: Bracewell & Giuliani LLP